PR Newswire
SAN DIEGO, June 29, 2017
SAN DIEGO, June 29, 2017 /PRNewswire/ -- ResMed (NYSE: RMD) today announced it will report its fourth quarter of fiscal year 2017 results on Tuesday, August 1, 2017, after the New York Stock Exchange market closes. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.
The earnings webcast is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at investor.resmed.com. Please go to this section of the website and click on the icon for the "Q4 2017 earnings webcast."
Please note that we do not use outside phone lines to access the earnings call.
International earnings webcast times will be:
Tuesday, August 1, 9:30 p.m. | London | |||||||||||
Wednesday, August 2, 6:30 a.m. ARIVA.DE Börsen-GeflüsterWerbung Weiter abwärts?
Morgan Stanley
Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie hier: ME5SUH,. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Kurse | Sydney |
A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from August 1, 2017, until August 15, 2017, at:
US: | +1 800-585-8367 |
Outside US: | +1 416-621-4642 |
Passcode: | 48372777 |
About ResMed
ResMed (NYSE: RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 3 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world's best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries. ResMed.com | Facebook | Twitter | LinkedIn.
For media | For investors |
Alison Graves | Agnes Lee |
+1 858-836-6789 | +1 858-836-5971 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/resmed-to-announce-fourth-quarter-fiscal-year-2017-results-300482154.html
SOURCE ResMed Inc.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.